A novel signature of the ligand and receptor genes associated with disulfidoptosis for prediction of prognosis, immunologic therapy responses in hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A novel signature of the ligand and receptor genes associated with disulfidoptosis for prediction of prognosis, immunologic therapy responses in hepatocellular carcinoma

Published:2023-09 Issue:9 Volume:9 Page:e19502
ISSN:2405-8440
Container-title:Heliyon
language:en
Short-container-title:Heliyon

Author:

Fu Chong^ORCID,Cheng Chang,Zhang Yanping

Funder

Wannan Medical College

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference34 articles.

1. Global, regional and national burden of primary liver cancer by subtype;Rumgay;Eur. J. Cancer,2022

2. Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA A Cancer J. Clin.,2021

3. Clinical practice guidelines and real-life practice in hepatocellular carcinoma: a Chinese perspective;Xie;Clin. Mol. Hepatol.,2023

4. Cell death-related molecules and biomarkers for renal cell carcinoma targeted therapy;Lai;Cancer Cell Int.,2019

5. Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer;Liu;Nat. Cell Biol.,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP